News Releases

From scientific discoveries to promising clinical trials, City of Hope constantly advances new and better ways to improve the lives of people here and throughout the world.

You can find the latest information on our research, clinical and educational programs through this listing of current press releases.

City of Hope physician-scientist is named the Arthur M. Coppola Family Chair in Supportive Care Medicine

December 6, 2018

William Dale, M.D., Ph.D., has been named the Arthur M. Coppola Family Chair in Supportive Care Medicine in recognition of his 20 years of work helping patients and their families make informed medical decisions that improve quality of life.

City of Hope clinical and laboratory investigators present new research at the 60th American Society of Hematology meeting

December 4, 2018

City of Hope physicians and researchers at the American Society of Hematology (ASH) meeting in San Diego presented clinical trials for novel leukemia and lymphoma treatments that could improve outcomes for patients.

City of Hope doctors present new research on CAR T cell therapy, bone marrow transplants and other treatments for blood cancers

November 19, 2018

City of Hope announced today that it will present data on new findings on immunotherapies, including CAR T cell therapy, bone marrow transplants and other treatments for blood cancers, at the American Society of Hematology (ASH) Annual Meeting Dec. 1-4 in San Diego.

City of Hope, TGen announce letter of intent to build cell therapy manufacturing facility in Phoenix

November 1, 2018

City of Hope, TGen announce letter of intent to build cell therapy manufacturing facility in Phoenix. The move would enable the organizations to meet a demand for clinical cell therapies that is expected to grow 42 percent annually over the next decade.

City of Hope opens first-of-its-kind CAR T clinical trial for patients with HER2-positive breast cancer that has spread to the brain

October 30, 2018

Women with HER2-positive breast cancer that has spread to the brain need more treatment options, and City of Hope and Mustang Bio Inc. are meeting that challenge. The immunotherapy trial is the first to deliver CAR T cells directly to the brain of HER2-positive breast cancer patients with brain metastases.

City of Hope appoints new senior vice president, chief marketing and communications officer

October 29, 2018

John Weston has been appointed senior vice president and chief marketing and communications officer of City of Hope, a world-renowned independent cancer research and treatment center, effective today.

Real estate industry raises $1 million for City of Hope at gala honoring Yat-Pang Au of Veritas Investments

October 19, 2018

The 2018 City of Hope gala campaign honoring Yat-Pang Au, CEO of Veritas Investments, with The Spirit of Life® Award, raised $1 million for the national research hospital’s fight against cancer and life-threatening diseases.

City of Hope’s Xiuli Wang, Ph.D., awarded $3.8 million by California Institute for Regenerative Medicine to develop immunotherapy trial for HIV

October 18, 2018

The California Institute for Regenerative Medicine today awarded City of Hope’s Xiuli Wang, Ph.D., $3.8 million to develop CAR T cells that can target and kill HIV-infected cells. The treatment will also use the cytomegalovirus vaccine to stimulate the immune system to proliferate and maintain the CAR T cells.

City of Hope researchers develop a DNA molecule that may eventually be used as a ‘vaccine’ against prostate cancer

October 18, 2018

The scientists developed a synthetic DNA molecule that disables tumor defense systems while inducing immune responses – a two-step immunotherapy that eliminated difficult-to-treat prostate cancer in experimental models

Five major employers choose City of Hope’s renowned cancer expertise for their employees and join Quantum Health’s innovative Personal Precision Oncology Management program

October 16, 2018

Following the unique collaboration made public in March 2018, Quantum and City of Hope today announced the first five major employers that have implemented the innovative Personal Precision Oncology Management program. The program allows employers to provide a range of premier clinical cancer support services to their employees and leading expertise to those employees’ physicians regardless of where they live.